Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron R Hansen

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 25, 2025
ARTSCAN: Time to Rethink De-escalation in LA-HNSCCLaura Tam, Aaron R Hansen
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2016
Immune-Related Adverse Events Associated with Immune Checkpoint InhibitorsDaphne Day, Aaron R Hansen
Annals of Translational Medicine|September 3, 2019
The PD-1/PD-L1 pathway in advanced prostate cancer-have we milked this cow?Sarah L Picardo, Aaron R Hansen
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
Salvage chemotherapy for metastatic germ cell tumours: The known unknownsAaron R Hansen, Philippe L Bedard
Critical Reviews in Oncology/Hematology|April 22, 2017
A comprehensive review of immunotherapies in prostate cancerManuel Caitano Maia, Aaron R Hansen
JAMA Oncology|November 13, 2015
PD-L1 Testing in Cancer: Challenges in Companion Diagnostic DevelopmentAaron R Hansen, Lillian L Siu
Cancer Cell|October 13, 2020
Dual Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancer: Just a Gambit or Real CheckMate?Brooke E Wilson, Aaron R Hansen
Breast Cancer Research : BCR|October 19, 2013
Clinical application of high-throughput genomic technologies for treatment selection in breast cancerAaron R Hansen, Philippe L Bedard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?Aaron R Hansen, Lillian L Siu
Frontiers in Pharmacology|June 14, 2024
Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r futureHarriet Lampe, Laura Tam, Aaron R Hansen
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|September 25, 2025
ARTSCAN: Time to Rethink De-escalation in LA-HNSCCLaura Tam, Aaron R Hansen
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2016
Immune-Related Adverse Events Associated with Immune Checkpoint InhibitorsDaphne Day, Aaron R Hansen
Annals of Translational Medicine|September 3, 2019
The PD-1/PD-L1 pathway in advanced prostate cancer-have we milked this cow?Sarah L Picardo, Aaron R Hansen
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
Salvage chemotherapy for metastatic germ cell tumours: The known unknownsAaron R Hansen, Philippe L Bedard
Critical Reviews in Oncology/Hematology|April 22, 2017
A comprehensive review of immunotherapies in prostate cancerManuel Caitano Maia, Aaron R Hansen
JAMA Oncology|November 13, 2015
PD-L1 Testing in Cancer: Challenges in Companion Diagnostic DevelopmentAaron R Hansen, Lillian L Siu
Cancer Cell|October 13, 2020
Dual Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancer: Just a Gambit or Real CheckMate?Brooke E Wilson, Aaron R Hansen
Breast Cancer Research : BCR|October 19, 2013
Clinical application of high-throughput genomic technologies for treatment selection in breast cancerAaron R Hansen, Philippe L Bedard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?Aaron R Hansen, Lillian L Siu
Frontiers in Pharmacology|June 14, 2024
Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r futureHarriet Lampe, Laura Tam, Aaron R Hansen
Pageof 18